Form 4: DocuSign Director Marrs Sells Shares

DocuSign Director Anna Marrs acquired shares via RSU vesting and subsequently sold a portion of her common stock holdings under a pre-arranged 10b5-1 plan.

Summary

• DocuSign Director Anna Marrs reported changes in her beneficial ownership of company securities.
• On February 28, 2026, Marrs acquired 729 shares of common stock through the vesting of Restricted Stock Units (RSUs).
• On March 3, 2026, Marrs sold 365 shares of DocuSign common stock at a price of $45.02 per share.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Marrs to pre-arrange trades.
• Following these transactions, Marrs directly owns 11,889 shares of DocuSign common stock.
• Marrs also holds 729 Restricted Stock Units (RSUs) after the reported transactions, which represent a contingent right to receive one share of common stock per RSU.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While it involves insider selling, the transaction was pre-planned under a 10b5-1 plan, which often mitigates negative sentiment associated with insider dispositions.

Positives

• The sale was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled transaction rather than an immediate reaction to new information.

Negatives

• A director selling shares, even under a 10b5-1 plan, can sometimes be perceived negatively by the market, as it reduces insider ownership.

Future Outlook

The Restricted Stock Units (RSUs) held by Anna Marrs have a vest commencement date of May 29, 2025, and will vest in equal quarterly installments over one year, with the final installment vesting on the earlier of the company's next annual meeting or the one-year anniversary of the grant, subject to continued service.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are routinely reported via Form 4 filings. The use of a Rule 10b5-1 plan for the sale is a common practice among corporate insiders to manage their equity holdings in a compliant manner, mitigating concerns about trading on non-public information. This filing is specific to an individual director's equity management and does not directly reflect broader industry trends for DocuSign's sector.

Stakeholder Impact

• Shareholders: Minor impact due to a director's pre-planned sale, potentially signaling a slight reduction in insider conviction, but largely offset by the 10b5-1 plan.

Next Steps

• Future vesting of remaining Restricted Stock Units (RSUs) held by Anna Marrs according to the established schedule.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions by a director, involving RSU vesting and a pre-planned sale under a 10b5-1 plan. Such transactions are common for executives managing their equity compensation and typically do not indicate a significant shift in the company's fundamental outlook or warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide new information to alter the investment thesis.

Keywords

DocuSign, DOCU, Anna Marrs, Insider Trading, Form 4, Stock Sale, RSU Vesting, 10b5-1 Plan, Director